Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

BACKGROUND: Ipilimumab improves the survival of metastatic melanoma patients. Despite documented, durable objective responses, a significant number of patients fails to benefit from treatment. The aim of this study was to identify an upfront marker for treatment benefit. METHODS: A total of 187 meta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Ferrucci, P F, Gandini, S, Battaglia, A, Alfieri, S, Di Giacomo, A M, Giannarelli, D, Cappellini, G C Antonini, De Galitiis, F, Marchetti, P, Amato, G, Lazzeri, A, Pala, L, Cocorocchio, E, Martinoli, C
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Translational Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580390/
https://ncbi.nlm.nih.gov/pubmed/26010413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.180
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars